Anat Ashkenazi Wikipedia, Lilly, Linkedin, New Gogole Cfo

Anat Ashkenazi Wikipedia, Lilly, Linkedin, New Gogole Cfo:-Anat Ashkenazi is a renowned financial executive who has made a significant impact in the pharmaceutical industry. Born in 1964, Ashkenazi has spent over two decades at Eli Lilly, where she rose through the ranks to become the Chief Financial Officer (CFO). Her impressive career has earned her recognition as one of the most influential women in finance.

Anat Ashkenazi Wikipedia, Lilly, Linkedin, New Gogole Cfo

Anat Ashkenazi Bio

NameAnat Ashkenazi
BirthdateNot Available
BirthplaceNot Available
OccupationExecutive President and Chief Financial Officer, Eli Lilly and Company
Notable WorkVarious roles at Eli Lilly and Company, including Senior Vice President, Controller, and CFO of Lilly Research Laboratories
BookNot Available
FriendshipNot Available
CareerJoined Eli Lilly in 2001, held various roles across finance, strategy, and operations, currently serves as Executive President and CFO
LegacyServed on the board of directors at Maravai Life Sciences and previously at Varian Medical Systems
Net WorthAt least $319,000 as of February 2021
Salary$276,809 as Independent Director at Varian Medical Systems

Anat Ashkenazi Early Life and Education

Ashkenazi was born in 1964 and holds a Bachelor’s degree in economics and business administration from the Hebrew University. She also holds an MBA from Tel Aviv University.

Anat Ashkenazi Career at Eli Lilly

Ashkenazi joined Eli Lilly in 2001 and has since held various roles across finance, strategy, and operations. She served as the Senior Vice President, Controller, and CFO of Lilly Research Laboratories, overseeing the financial functions of various departments. Ashkenazi also led the corporate strategy team and business transformation office, and served as CFO for several global business areas.

Anat Ashkenazi Appointment as Google CFO

In June 2024, Ashkenazi was appointed as the new Chief Financial Officer (CFO) of Alphabet, the parent company of Google. She succeeds Ruth Porat, who will transition to a new role as President and Chief Investment Officer. Ashkenazi’s tenure as CFO will commence on July 31, 2024.

Anat Ashkenazi Experience and Achievements

During her tenure at Eli Lilly, Ashkenazi played a crucial role in the company’s growth and success. She oversaw the launch of several new medical treatments, including the widely acclaimed diabetes drug Mounjaro, which quadrupled Lilly’s stock value. Ashkenazi’s expertise in finance and strategy has been instrumental in Lilly’s transformation into one of the world’s most valuable healthcare companies.

Anat Ashkenazi Board Memberships

Ashkenazi currently serves on the board of directors at Maravai Life Sciences and has previously served on the board of radiation therapy leader Varian Medical Systems.

Anat Ashkenazi Social Accounts

InstagramVisit
TwitterVisit
FacebookVisit

FAQs

What is Anat Ashkenazi’s background?

Anat Ashkenazi is a financial executive with over two decades of experience at Eli Lilly. She holds a Bachelor’s degree in economics and business administration from the Hebrew University and an MBA from Tel Aviv University.

What is Anat Ashkenazi’s role at Eli Lilly?

Ashkenazi served as the Chief Financial Officer (CFO) of Eli Lilly, overseeing the financial functions of various departments and leading the corporate strategy team and business transformation office.

Why did Anat Ashkenazi leave Eli Lilly?

Ashkenazi left Eli Lilly to pursue an opportunity outside the pharmaceutical industry. She will remain in her position and as a member of Lilly’s Executive Committee until July 2024.

What is Anat Ashkenazi’s role at Google?

Ashkenazi was appointed as the new Chief Financial Officer (CFO) of Alphabet, the parent company of Google. Her tenure as CFO will commence on July 31, 2024.

What are Anat Ashkenazi’s achievements at Eli Lilly?

Ashkenazi played a crucial role in the launch of several new medical treatments, including the widely acclaimed diabetes drug Mounjaro, which quadrupled Lilly’s stock value. She also oversaw the company’s transformation into one of the world’s most valuable healthcare companies.

What are Anat Ashkenazi’s board memberships?

Ashkenazi currently serves on the board of directors at Maravai Life Sciences and has previously served on the board of radiation therapy leader Varian Medical Systems.

Also Read:

Leave a Comment